Nephrotect

Acetylcysteine, the active ingredient in Nephroprotect, is a compound presented as an injectable solution for intravenous use. It is combined with glycine, L‑lysine acetate, L‑tryptophan, glycyl‑tyrosine, L‑arginine and L‑histidine and is intended to support renal function and oxidative balance in clinical settings. GNH USA supplies Nephroprotect as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

Nephroprotect contains a blend of amino acids and acetylcysteine; currently it is not associated with specific approved therapeutic indications.

Nephroprotect may be associated with adverse reactions typical of intravenous amino‑acid and acetylcysteine preparations.

Common Side Effects: - Nausea or vomiting: mild gastrointestinal discomfort after infusion. - Flushing or warmth: transient sensation at the infusion site. - Mild hypotension: temporary drop in blood pressure during administration. - Rash or pruritus: skin irritation or itching. - Headache: occasional mild headache post‑infusion.

Serious or Rare Side Effects: - Anaphylactoid reaction: sudden respiratory distress, wheezing or bronchospasm. - Severe hypotension: marked drop in blood pressure requiring intervention. - Angio‑edema: swelling of face, lips or throat. - Hepatic enzyme elevation: significant increase in liver function tests. - Hemolysis: rare destruction of red blood cells. - Acute renal dysfunction: unexpected worsening of kidney parameters.

Nephroprotect should be administered under medical supervision with attention to patient history and infusion parameters. - Allergy assessment: verify no known hypersensitivity to acetylcysteine or any amino‑acid component. - Cardiovascular monitoring: observe blood pressure and heart rate during infusion. - Respiratory status: watch for signs of bronchospasm, especially in asthmatic patients. - Renal function: evaluate baseline creatinine and adjust infusion if renal impairment is present. - Drug compatibility: ensure compatibility with other IV solutions before mixing. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Nephroprotect may interact with certain medications; monitoring is advised.

Major Interactions (Avoid): - Nitroglycerin: concurrent use can cause severe hypotension. - Warfarin or other anticoagulants: may enhance anticoagulant effect, increasing bleeding risk.

Moderate Interactions (Monitor Closely): - ACE inhibitors: potential additive effect on blood pressure. - Diuretics: may alter electrolyte balance when combined. - Other antioxidant agents: possible redundancy or altered pharmacodynamics.